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Abstract
This paper analyzes the paths of emerging technologies in developing countries, 
particularly considering its distributive dimension along the chain of functions, from 
knowledge production, to the technology’s production/provision, its incorporation into 
the productive system, and to its more generalized access and use. Two contrasting 
countries, Argentina and Costa Rica, set the context of study of these paths, the different 
conditions through which they make their way across sectors and actors, their functions 
and roles, and the type of distributive channels involved. 
The analysis of the distributive patterns of emerging technologies must include at 
least two intertwined levels: at the level of knowledge production, diffusion and access, 
and the second related to technology’s diffusion-commercialization, access and use. The 
twofold analysis involve a common emphasis on the identification and analysis of who 
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produces/gets what, how and when, and on the channels of distribution that contribute (or 
not) to the breadth and depth of the technology. More in particularly, it considers those 
policies, organizations and/or institutions that substantially influence/shape the way in 
which the technology penetrates society. In some cases these have to do with establishing 
channels for bridging knowledge production and use, while in others their contribution is 
towards the expansion of technological access and appropriation. It also looks at the 
different roles of policies along each phase of the technology. 
This paper argues that at the level of knowledge production, public research 
organizations (national and/or international) are fundamental for catalyzing the 
expansion of the distributive path, in spite of differences and peculiarities of the 
technologies. Yet at the level of the distribution of the technology, this role is not always 
embraced by a specific actor or by policies, in which cases distributive paths are 
interrupted, and pockets of population remain outside from the technology’s path. 
It directly results from a large research project, RESULTAR2, oriented to study 
the distributive consequences of emerging technologies in five countries of the Americas 
(Argentina, Canada, Costa Rica, Jamaica and United States), and concentrated on two 
sets of emerging technologies: biotechnologies (GM, tissue culture, and recombinant 
insulin) and ICTs (Open source software and Mobile Phones). Moreover, RESULTAR 
attempts to: “(1) describe the dynamics that link emerging technologies to patterns of 
inequality;  (2) identify the roles of public interventions in those dynamics; and (3) 
develop a framework that policy actors can use prospectively to analyze the distributional 
valence of a specific new technology in a particular national context.”3. 
This paper takes some distance from the focus on outcomes to concentrate on the 
paths of these technologies across the population, focusing on the mechanisms and 
channels through which they are accessed and utilized. In particular it draws on 40 in-
depth interviews conducted to a wide range of actors, including researchers, policy-
makers, technology users, NGOs, and productive actors related to the five technologies 
in the two countries4. 
                                                       
2 This paper has substantially benefited from insights and discussions at RESULTAR workshops 
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3 For more details see (Cozzens 2007)
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Setting the context 
Among other characteristics, disparities and inequalities pulse the life of Latin 
America. Disparities in consumption is only one side of it, aggravated by enormous 
inequalities in the capabilities and freedom to choose what life to be lived (de Ferranti, 
Perry et al. 2003).  The setting of this paper is defined by two Latin American countries, 
largely different but with a common Spanish colonial root. They serve as boundaries, 
delimiting the settings where to trace the paths and connections between science and 
technology, and outcomes. Argentina and Costa Rica conform a contrasting duo. 
Argentina is the second larger country in South America after Brazil, with near 40 
million people. Richly endowed with natural resources and very fertile lands, 
Argentineans are often facing deep fluctuations between high growth and drastic 
economic crisis and political instability. An unfortunate illustration of these waves is the 
the 2001 crash of the Plan de convertibilidad (Convertibility Plan) that fixed the 
Argentinean Peso to the US Dollar: 1 peso – 1 dollar during the 1990s. After a profound 
socio-economic crisis, it followed the political conflict and the resignation of the 
President (Rock 2002), while banks were crowded with individuals attempting to cash 
their money as a result of the ‘corralito’ (little fence) implemented by the Economic 
Ministry to limit the volume of withdraws. 
Turmoil impregnates the country’s history since its independence in the 1820s. 
Crisis and recovery conform the limits of a pendulous movement by which the country 
passed from being one of the richest in the world at the beginnings in the early 20th
century, to a serious impoverishment one century later. Between the end of the 18th
century and the beginning of the 19th, it was the country with higher sustained growth 
rate over a period of time (Skidmore and Smith 2005). The question of why such a shift, 
points at the burden of rent-seeking governments and policy elites. Della Pollera and 
Taylor (2003) argue that the country “missed the opportunity to design the right 
institutions that would secure sustainable growth and insulate the society from the 
voracity of politicians and rent seekers” (p. 374) (della Paolera and Taylor 2003). This 
perverse orientation is aggravated by a ‘short termism’ by which the “present time is 
often purchased at the cost of the future’s”.
A current picture of the country shows high alphabetization (97.2%), high life 
expectancy (74.2), and a GDP per capita of US$ (PPP) 14,280; the nation is then placed 
among the group of high human development (#38), the first Latin American country in 
that group, seconded by Chile (UNDP 2007).  That reality coexists with regional 
disparities along factors such as access to and quality of education and health, 
illustrations of the ‘other Argentina’. Inequality levels are relatively high, with a Gini 
Index of 51.3 (year 2004) (note that the 2000 survey in US indicates an index of 40.8) 
(UNDP 2007).  
Costa Rica in turn, a Central American country with 4.5 million people, is well 
known for the pervasiveness of its democratic value system along with a tradition 
towards peace and conflict resolution, in a context characterized by stability, both 
political and economically. Its pacifist trajectory led the ex-President Oscar Arias 
Sánchez to be awarded with the Peace Nobel Prize in 1987 for his efforts to get the 
region out of armed conflict. Costa Rica was the only country that did not suffer violent 
conflicts in the 1980s, and proof of its pacifist tradition is its abolition of the Army in 
1949, under the Presidency of Figueres Ferrer. 
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A strong welfare state, combined with a tradition of a more equalitarian society 
make Costa Rica unique compared to its Central American neighbors. Traditionally 
Costa Ricans’ have proudly seen their country as an agricultural, pacifist and equalitarian 
republic, oriented to democratic values and social justice (Molina Jiménez 2003). 
Emerging and emerged technologies
‘Emerging technologies’ refer to technologies that are new, science-based, rapidly 
expanding, and with significant market potential (Cozzens, Gatchair et al. 2005). 
Mytelka (2004) defines ‘new wave technologies’ as: “…anchored in the sciences and 
their knowledge base has developed less as the result of incremental change along a 
single technological trajectory than through a combination of several distinct trajectories 
with different scientific roots. These diverse roots, however, increasingly share a 
common platform –at the nano level of photons and genes. As a result, the research 
laboratory has become central in the discovery and development of new products and 
processes based on these technologies” (Mytelka 2004) (pp.396-7). 
The focus on ‘emerging technologies’ of this paper and of the larger Resultar 
project is because of several reasons. First, their novelty provide the opportunity to 
observe ongoing change in developed and developing countries, where the supporting 
techno-economic networks are still young and malleable, thus providing a place for 
public interventions towards equality. Second, their research-based character might make 
them costly and demand high-level skills, which turn them with higher potential for 
increasing inequalities in access and employment. Third, they are at the crossroads 
between national-international processes, both in terms of the technologies creation-
diffusion patterns and regarding inequalities. They enable to trace this (dis)connections 
within the national borders but related to more global dynamics (Cozzens 2007). Yet the 
technologies analyzed here are not emerging sensu stricto, rather some time has passed 
since their emergence. It was necessary to have this lag for technologies to establish in 
the context of developing countries. 
The analysis of emerging technologies must include two intertwined layers: that 
referring to the end-products or devices, and the one referring to the scientific and 
technological processes behind them.  
Paths and distributive channels of emerged technologies
The next section briefly describes the technologies to then concentrate on the 
paths and circuits generated along each one of them. 
Brief characterization of the technologies
1. Biotechnology: Tissue culture, GM Crops and Recombinant Insulin 
Both Argentina and Costa Rica held a strong research tradition and capacities 
around life sciences, though biology sciences have been the core strength of the latter. 
The former has a strong and well known reputation in this area, with three Nobel prizes: 
in Physiology and Medicine (Bernardo Houssay, 1947), in Chemistry (Luis Leloir, 
1950), and in Medicine and Pharmacology (César Milstein, 1984). R&D investment 
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however is low, reaching 0.4 % of GDP (2000-2005)5 (UNDP 2007), a trend not 
exclusive to Argentina but to Latin America in general. 
In Costa Rica biology has concentrated research and development efforts since 
the 19th century (Rocha 2000; Zeledón 2000).  The country is one of the richest 
reservoirs of biodiversity in the world.  Its biological diversity and the concern over the 
use of natural resources have been at the center of science-making in Costa Rica. This 
accumulation is evidenced through well-established achievements such as the production 
of anti-ophidian serum in the Clodomiro Picado Institute6 (University of Costa Rica) that 
is exported to many countries, or the internationally known journal Tropical Biology
(Revista de Biologia Tropical), which is indexed in the Science Citation Index 
(Bortagaray 2007 ).
Plant tissue culture 
Plant tissue culture refers to the regeneration of a whole plant from a single cell 
grown in sterile and controlled conditions, which locus is a clean room in a laboratory. It 
is based on cells that could be obtained from different sources such as the leaf, root, 
anther, protoplast, meristem or could be grown in sterile culture medium within a test 
tube. 
The history of this technique goes back to the end of the 19th century to the basis of 
cell theory developed by Schleiden (1838) and Sehwann (1839) who independently
stated that cells have an autonomic capacity and a totipotent character. But it took 130 
years to support the thesis of cell totipotency with experimental evidence (Gautheret 
1983).
In vitro culture is a special type of vegetative propagation but with some advantages 
compared to conventional methods, including controlling for sterilized conditions, 
shorter time of propagation, exclusion of pathogens, and potential of longer conservation. 
In vitro culture has several potential applications, including: micropropagation of 
pathogen free plants, development of new genotypes, conservation of germplasm banks, 
and culture in bio-reactors to extract secondary metabolites for industrial and/or medical 
purposes (Capdevielle and Castillo, INIA). 
GM Maize
GM crops refer to those which gene structure is scientifically altered and 
manipulated. Different processes are involved, from isolation to manipulation, transfer 
and reintroduction of DNA into cells or model organisms. rDNA technologies 
applications to plants did not happen until the early 1980s. One of the most extended uses 
on genetic engineering on plants has been for herbicide resistance (Sharp 1995).
Recombinant Insulin
Diabetes mellitus is a widespread disease affecting large number of people across 
the globe. One of the responses pushed forward by drug companies to control for the 
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human body’s impairment of insulin production is recombinant insulin, a biotechnology-
based product. R- insulin is synthesized in bacterial or yeast cells which genetic material 
is modified to include the insulin’s nucleotide sequence coding (Walsh 2005) (Gatchair, 
Bortagaray et al. 2009). The global supply of r-insulin is concentrated in three 
multinational pharmaceuticals: Lilly, Novo Nordisk, and Sanofi Aventis.
The type and doses of insulin depend on prescription, diagnosis and the 
physician’s preferences. A good diagnosis, changes in life style and blood sugar tests to 
establish the necessary quantity of insulin are key preconditions, strongly dependent on 
health care access. For type I diabetics, access to insulin is a matter of life or death 
(Gatchair, Bortagaray et al. 2009).
2. Information and Communication Technologies
Open Source Software 
Open source software constitutes an alternative model to the traditional 
proprietary software (PS). The actual products developed under this model crosscut the 
different broad types of software: operating systems, application tools, and application 
solutions (Mowery 1999). Differences between PS and OSS are many and along several 
dimensions. First, the development of OSS is not carried on by a defined 
individual/organization/company, but distributed among several individuals, and built 
over time, as the source code is open and users keep contributing to its development. 
Secondly, it constitutes an alternative business model compared to PS. While in the latter 
the benefits are mainly associated to the software’s IPRs, through royalties or licenses, in 
the former the software can be distributed, and copied with no or few restrictions. Lower 
costs, efficiency and individual freedom are some of the reasons for its appeal (Thakur, 
Beckert et al. 2009b). 
Mobile Telephones 
Mobile phones are increasingly serving as platforms for the development of other 
sectors, while also enable access to other fundamental services such as health.   
Paths of technological production, access and use
Tissue cultured banana in Costa Rica
Banana is the first item in the export of primary products in Costa Rica. Almost 
all exported banana originates in the laboratory as tissue cultured plants.  Banana 
research and development, and the production of tissue cultured plants take place in the 
country, and is handled by local firms, though there are also imported plants from Israel.   
Exporters of banana have a well-established system, including both R&D and 
production of tissue-cultured plants. R&D concentrates at CORBANA, the national 
corporation of Banana, a levy based organization. From each box of banana exported 
CORBANA gets USD 5 cents, and from this, USD 2 cents go into the R&D department. 
CORBANA’s research agenda is decided based on farmers’ needs and problems. The 
production of commercializable tissue culture plants of banana is supplied by few local 
laboratories, plus some that are imported from Israel, as mentioned above.     
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On the other hand, CATIE has banana as one of its research areas. CATIE, the 
Centre of training and research on Tropical Agriculture, is an international organization 
created in 1973, after IICA’s initiative and supported by Costa Rica’s government. It 
dedicates to the training and education of human resources7 in agriculture-related areas. 
Biotechnology is one of its core strengths; particularly related to Musaceas, apart from 
cacao, coffee, etc.. 
Small farmers and tropical communities are at the core of its mission. It used to 
operate based on donations, but gradual budget constraints are pushing towards 
partnerships with large companies.
Non-exporter small banana farmers are not under the scope of CORBANA. That 
niche has been only covered by CATIE, which has been working with small farmers not 
only in Costa Rica but in the region. These small farmers plant banana as part of a 
broader mix. They tend to combine coffee, banana and plantain for instance. Banana 
plants provide a good shade for coffee. The area where CATIE is located used to be a 
banana growing area, later dismantled by the Panama malady. Few years ago banana was 
re-introduced as a result of a Ministry’s of Agriculture program. For one year the 
initiative provided farmers with plants (conventional plants) and the technological 
package. It is easier to deal with a banana plantation than with plantain, which is more 
susceptible. CATIE involves small farmers in their training and experiences, providing 
them with tissue-cultured plants. 
Tissue cultured potato in Argentina
In Argentina, almost all potato seeds are in vitro originated. They are grown in 
few regions, isolated and semi-desertic regions. Pathogen free plants combined with the 
substantial decrease in the timing of the process are key reasons to choose for in vitro 
plants. The industry of seed production is locally established, in part as a consequence of 
a government decision from 1993 of closing the import of potato seeds (tubers and mini-
tubers) from other countries to promote a local industry. 
There are two parallel markets with different rules. One is the potato grown for 
industrial processing, with pre-established contracts and clear prices. The other is the 
market of fresh potato, a centralized market with obscure rules and uncertain prices. As 
for growers, the typical farmer exploits 200 or 300 hectares, rents the land, and owns or 
rent the machinery. Potato farmers are ‘gamblers’, can get multimillionaire one year, and 
the next go into bankrupt. 
Access to seeds is through the market. Varieties are developed locally, mainly by 
INTA. There are other potato growers in the north of the country, small farmers who are 
pointing at a gourmet niche, and recouping pre-colonial crops, such as quinoa, which was 
prohibited in colonial times and substituted by wheat.
                                                       




Argentina’s core strengths on life sciences are shown in the case of insulin 
research and development. Argentina has a long history in the production of insulin, 
bovine insulin in particular, and started almost by chance when in 1923 at the Malbran 
laboratory a medical doctor, Dr.Sordelli, became the first scientist who was able to 
depurate bovine insulin, filter a certain amount of pathogens, established a production 
protocol and packed it, before Eli Lilly (Bisang, Cogliati et al. 1986). The process of 
filtering the pancreas, leaving aside all impurities was a critical bottleneck. Large 
quantities of bovine pancreas used to be literally thrown to the trash, as the meat 
industry, a major sector in the national economy, left several residuals, which were later 
turned into by-products, one of them being the production of biologically-based 
medicaments. Porcine insulin came later as a more suitable drug due to its larger 
similarity with human insulin. The problem is the cost. If bovine insulin costs 1, porcine 
insulin costs 3 and recombinant costs 10. 
In 2004 a local company, Beta, decided to manufacture r-insulin, based on 
technology developed by CONICET (CONICET 2004). In 2007 the firm was sold to
Sanofi-Aventis. In 2006 other local company, Denver Farma, announced the introduction 
in the market of the first r-insulin produced in Argentina (‘Densulin’), based on a joint 
venture between the company and Diosynth, one that is part of the Dutch group Akso 
Nobel (Farma 2006).  Other local biotechnology company with a scientific trajectory and 
recent promising achievements is BioSidus. Their approach is different: they are 
developing a pharmaceutical dairy, growing GM cows. It is a medium term project; in 
2007 was born the first transgenic cow (Patagonia) for insulin production8.
In Costa Rica insulin is imported by the CCSS, which provides health care to 
most of the population. In both countries, the public health care system operates for the 
working population. In Argentina, health care is publicly provided. Universal coverage to 
lower income individuals involves access to medical infrastructure, professionals, 
internment, prevention campaigns, vaccination plans, free provision of medicaments, 
etc., at three administrative levels: the national, provincial and municipal. But between 
these three there are some gaps, leaving some individuals without proper coverage. 
Individuals’ access to health care varies depending on capacities and location within the 
labor market (Anlló and Cetrángolo 2008). The Ministry of Health is responsible for 
national health policies and programs, and for norms and actions that enable the 
coordination of the different subsectors (Tobar, Montiel et al. n/d)
In Costa Rica the CCSS was created in 1941 to handle workers’ health care, on a 
solidarity basis: the worker, the employer and the State, each one pay part of it. One 
worker in the household is enough to have the whole family covered. Around 95% of the 
population is covered with health insurance, that is the economically active population. 
                                                       
8 Their approach uses the mammal gland as a bio-reactor to get the insulin, which is going to be 
purified from the milk. The mammal gland contains the gene precursor of human insulin, and that 
molecule is produced with the other natural proteins of milk. The milk with this precursor of 
human insulin is just an intermediate phase in the production process. The next phase is to 
optimize the isolation and purification processes to get the milk-based human insulin, at an 
industrial scale. They are waiting for the expansion of the transgenic rodeo, and their maturity to 
get the milk, and thus begin the process of filtrating and purifying the insulin.
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The system is benevolent, and grants health care to whoever requires it. First health care 
is provided and then it is assessed whether can pay for it or not, is legal resident or not. 
An official list of medicaments is defined, and within that list no co-payment is 
required. Even some medicaments that are not included in the official list get paid by the 
CCSS. Insulin is fully provided, and the insulin included in the official lists are Nph and 
Ersalina (Gatchair, Bortagaray et al. 2009).
GM maize9
Argentina is the second largest grower of GM crops after United States (57.7 
million hectares of GM crops) with 19.1 million hectares of soy, maize and cotton, which 
account for 19% of global biotech crop hectarage (James, 2007 #1348). Maize has had 
the highest improvement in performance in the last 30 years (Gear 2006).
Local R&D efforts on maize have been put in place in the country, mainly by 
universities and INTA, the national agricultural research organization. The country hosts 
a rich genetic variety, such that more than 40 local varieties have been identified 
(Eyherabide 2006). Along the history of maize improvement in Argentina, INTA has 
been a key player through its Maize improvement program (Bárcena 2004) implemented 
since 1962, strengthened by the establishment of a germplasm bank in 1969 (Eyherabide 
2006). INTA’s achievements have relied upon government support and close ties with 
CIMMYT10 in Mexico and CIAT in Colombia. 
Hybrid cultivars have been increasingly dominating the maize market, 
substituting open pollination varieties. Such was the massive adoption of hybrids in the 
1970s that looking back it turns into one of the main milestones of maize production in 
Argentina (Gear 2006). This shift obeys to different reasons, an important one being 
productivity, yet it has been accompanied by strong industrial interests given that the 
hybrids themselves embody the key for intellectual property protection (Rossi 2007). 
Hybrid seeds carry along a built-in advantage in terms of property protection, as they 
have to be re-purchased every season, which is very attractive for seed companies.  
According to an interviewee this explains why most local seed companies’ efforts have 
been in maize rather than in soy, as maize enables them to capture the rent. 
Access to GM maize is through the market, mainly sold as part of a package that 
includes not only the seeds but the fertilizer and often financial credit, which turns the 
offer more attractive. Progressively the agricultural landscape entails more GM maize, 
which nowadays accounts for more than 70% of the total maize planted area. Farmers’ 
                                                       
9 The case of GM in Costa Rica is not included in the analysis because even if there have been on 
one side, strong research capabilities around GM maize, rice and banana, and on the other, large 
quantities of GM seeds being planted in the country only for propagation purposes, no GM crop 
has been grown for consumption or commercialization within the country. The propagation of 
seeds has led to the authorization of 663 GMOs events between 1991 and 2004 (Cabrera 
Midaglia 2004): 54.4% in soy and 41.3% in cotton (for more details see (Bortagaray 2007 ). 
10 Both centers are members of the CGIAR network, the International Maize and Wheat 
Improvement Center-CIMMYT and the International Center for Tropical Agriculture-CIAT. 
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main reasons for adopting GM maize have to do with cost reduction as well as the 
simplification of the task by forgetting the insecticides, reducing the fungi and mico-
toxins, and its innocuousness over beneficial insects and vertebrates (Rossi 2007).
As for GM regulations, in Argentina they are distributed in two main bodies: the 
National Institute of Seeds (INASE), and the Secretary of Agriculture, Livestock, 
Fisheries and Food. The latter acts under the advice of the Advisory National 
Commission of Agro-Biotechnology (CONABIA) and the Office of Biotechnology. 
INASE is oriented to control the production and commercialization of seeds, including 
imports and exports. In practice the Institute’s ability to control all the volume of planted 
seeds across the country is rather limited. But in the case of maize, the main protecting 
instrument is the hybrid nature of most planted maize. On the other hand CONABIA is 
an advisory body on technical and bio-safety requirements. It involves representatives
from both, public and private organizations related to agro-biotechnology11. Its main role 
is to advise the Secretary of Agriculture on biotechnology related issues (GM being an 
important part of it), which ultimately holds the decision capacity. For instance between 
1991 and 2005, 922 vegetal GMOs have been assessed for their liberation in the 
environment (CONABIA s/f).
Mobile phones
The case of mobile telephones results in a unique story among these technologies, 
not only due to the associated high rate of penetration, but to the speed of their diffusion 
and breadth across different social layers. Access to mobiles does not seem to be a 
problem. The rate of penetration of mobile phones is very high in Argentina and 
moderate in Costa Rica. Data from 2007 suggests more than 100 subscribers per 100 
people in Argentina (40.4 million subscribers), while in Costa Rica the rate is 33.76 
subscribers per 100 person (1.5 million) (ITU 2007).    
Costa Rica has had a peculiar approach towards the provision of mobile services 
compared to Argentina, which more or less illustrates the general trend12. In Costa Rica, 
mobile phones have been managed monopolistically by a public agency, ICE, which 
accounts for the country’s provision of electricity and telecommunications. Here, the 
pattern is to some extent inverse to Argentina’s. Unlike in most other cases, in Costa 
Rica the handset is not subsidized, and getting the mobile line takes time after some 
bureaucratic procedures, but as a tradeoff phone call fees are very cheap compared to the 
region.  
In Costa Rica where the rationale behind the supply of mobile phones is that of a 
public service, there are not large differences between or within groups, even after 
distinguishing by income level (Monge and Hewitt 2006 ). In Argentina, the types of 
use are largely dependent on socioeconomic level. There, more than 90% choose the 
prepaid alternative (CNC n/d), while in Costa Rica that is not a choice. 
Mobile phone is the only case among the studied technologies in which local 
contribution to technological production/manufacturing is non-existing, both in 
                                                       
11 For more information, please see http://www.sagpya.mecon.gov.ar/new/0-
0/programas/biotecnologia/index_en.php
12 For more details, see (Thakur, Beckert et al. 2009a)
11
Argentina and Costa Rica. Handsets are imported, as well as the infrastructure for 
ensuring connectivity. The content is standardized, and for the most part is imported and 
provided as another component of the handset. 
Local inputs are the electro magnetic space, which is a key scarce public resource 
regulated and distributed by public agencies; the personnel working in the provision of 
infrastructure to terminals; engineering companies working in the planning and design of 
where to establish cells, terminals, etc.; and a customer service support related to each 
provider. In Argentina, there is an informal market around the unlocking of providers’ 
codes so that customers can interchange devices and service providers. In Costa Rica the 
monopoly involves a large extent of the chain of services, though the building of 
infrastructure required might or might not be carried on by this same agency. For 
instance, in the case of the provision of 3G the plan was to contract the installment of the 
infrastructure out from a third party.   
Another fundamental local component is the regulatory environment put in place 
to safeguard customers’ access.  Once again in the case of Costa Rica the very rationale 
of mobiles provision makes it unique. Access to mobile phones has been granted as a 
public service, and given the public monopoly, the same agency ICE provides the 
service, controls the phone lines and establishes the price of the public service. On the 
other hand, in Argentina the CNC controls the electro magnetic space, overviews the 
phone call and SMS rates that must be registered there by service providers and imposes 
the limits within which multinational companies play. In reality, scarce human and 
financial resources at the public regulatory entity prevent a symmetric game13. But the 
public regulatory body does aim at safeguarding a healthy competitive environment. 
The prevalent concern refers to access and do not focus much on use. Some 
existing practices act against customers’ freedom to choose, for instance:    
 Calling party pays system
 Numerical in-mobility 
 Local loop unbundling 
In Argentina most regulatory instruments concentrate on the provision of the 
service. There is not a corresponding tool or agency dedicated to the user, and the quality 
and conditions of such use. The choice for pre-paid systems constitutes an adaptive 
response from lower-income individuals to grant and expand their use. For the most 
cases, these are mainly preferred by lower-income as a mechanism for controlling the 
budget, though it is also chosen by middle income parents for their teens, even when end 
rates are more costly. Another group paying higher costs are those who do not have a 
mobile and have to call one, as fixed line–mobiles rates are higher than inter-mobile 
phone calls. This does not apply to Costa Rica where ICE publicly provides mobile 
phone services, together with fixed-lines and electricity.
                                                       
13 Personal interview, CNC representative, November 2007, Buenos Aires. 
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Final remarks, learnt lessons and the (policy) road ahead
The paper argues that the consideration of emerging/emerged technologies in 
developing countries must involve not only the metric of access, but also one related to 
types and conditions of use. Furthermore, an analysis concerned with distribution and 
distributive outcomes must bring into light those that for different reasons do not access 
get into the technology’s loop.    
Regulatory and policy instances focus on the beginning of the ‘pipeline’; that is 
the provision of the service or the product. In the case of mobiles in Argentina, the 
regulatory agency aims at ensuring a balanced competition and safeguards the existence 
of broad guidelines to prevent consumers’ lock in companies’ practices. The idea of a 
pipeline between technological supply and use seems to be underlining many of the 
existing institutional landscapes. The control is on technical requirements, but leaves out 
the concern on who gets what, how and when. What would happen if the pipeline would 
be extended up to the final user, considering the type and quality of use, and expanding it 
up to bring to light those who do not even access the emerging technology. 
Another open question is that of the (a)symmetry between regulatory 
organizations and multinational companies. In the case of mobile phones and in the 
health and agro-biotechnology sectors in Argentina, the scarcity of available resources 
makes an exhaustive control of MNEs difficult, at the least. The asymmetry between 
MNEs and regulating agencies leaves a gap that ultimately affects users and consumers. 
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List of acronyms
Country Organization 
Argentina ANMAT National Administration of Pharmaceuticals, 
Food and Medical Technology (1992)
CNC National Commission of Communications
CONABIA National Advisory Commission on Agro-
Biotechnology
INASE National Institute of Seeds
INTA National Institute of Agricultural Technology
ONTI National Office of ITs
SAGPyA Secretary of Agriculture, Livestock, Fisheries and 
Food
SENASA National Service of Agro-food Sanitary and 
Quality 
Costa Rica CATIE Tropical Agronomic Center of Education and 
Research
CCSS Costa Rican Agency of Social Security
CORBANA National Banana Corporation 
ICE Costa Rican Institute of Electricity
OFINASE National Office of Seeds
